Core Viewpoint - Terranet AB has successfully completed a rights issue that was oversubscribed, raising approximately SEK 15 million before issue costs, indicating strong shareholder confidence in the company's future development [2][3][5]. Rights Issue Outcome - The subscription period for the rights issue ended on June 11, 2025, with 10,349,896 units subscribed for with unit rights, representing about 74.6% of the rights issue [3]. - An additional 4,704,934 units were subscribed without unit rights, corresponding to approximately 33.9% of the rights issue, leading to a total subscription of 15,054,830 units, or approximately 108.5% of the rights issue [2][3]. Financial Impact - The rights issue will increase the number of shares by 166,568,568 B-shares, raising the total share capital from SEK 14,715,191.82 to SEK 16,380,877.50 [7]. - If all warrants of series TO9 B are exercised, the number of shares will further increase by 83,729,677 B-shares, raising the share capital to SEK 17,218,174.270 [8]. Warrants and Trading - Each warrant of series TO9 B allows the holder to subscribe for one new B-share at a price of SEK 0.18, with the subscription period set from December 1, 2025, to December 15, 2025 [9]. - Trading in paid subscribed units (BTU) will occur on Nasdaq First North Premier Growth Market until June 30, 2025, or until conversion into B shares and warrants [10]. Company Development - The proceeds from the rights issue will enable the company to advance its product and business development, particularly in the commercialization of its anti-collision system, BlincVision [6]. - Terranet aims to enhance urban traffic safety through innovative solutions for Advanced Driver Assistance Systems (ADAS) and Autonomous Vehicles (AV) [14].

The biopharmaceuticals industry is both exciting and risky for investors. Many leading growth stocks in the U.S. market are found in this sector, due to the significant rallies that biopharmaceutical companies experience when a key positive trial result is announced or an important drug receives government approval. On the other hand, a host of biopharma firms face near-constant threats of collapse, given that most of these companies lack sufficient revenue to sustain operations for long unless a breakthrou ...

Nurix Therapeutics (NRIX) Update / Briefing June 12, 2025 08:00 AM ET Speaker0 Welcome to the New York's Therapeutics twenty twenty five investor call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. I would now like to turn the conference over to Newark's President and CEO, Arthur Sands. Arthur, you may begin. Speaker1 Thanks, Paul. Welcome to our call and our presentation today entitled meeting the needs of patients with CLL and Waldenstrom's ...

LOWELL, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, announced a new suite of high performance RF solutions designed to meet the demanding requirements of advanced radar systems. Many of these solutions will be demonstrated in MACOM’s Booth 943 at the upcoming International Microwave Symposium (IMS) on June 17 to 19, 2025 in San Francisco, CA. S-Band (2 – 4 GHz): High Power GaN-on-SiC AmplifiersA new family of 65 V, 50-ohm ...

AI 搜索 Agent 产品 Genspark 近期被 Anthropic 官方点名了。 「 Less structure, more intelligence .」是 AI 搜索 Agent 产品 Genspark 一直以来坚持的基本原则。 Genspark 团队认为， 过度结构化的工作流程会限制创造力和深度，赋予专业 Agent 更多自主权，自由 选择并灵活运用多种工具来处理问题，反而能释放出更强的能力。 而 Genspark 灵活、能够动态协调的专业 Agent 的背后，是基于 Anthropic 的 Claude 模型的能力。 Anthropic 官网近期发布了一篇关于 Genspark 的案例研究文章，详细介绍了 Genspark 如何突破传统固定 搜索工作流程的局限、选择 Claude 实现自适应智能以及 Claude 如何驱动其动态协调的「Super Agent」 等内容。 以下为文章全文内容。 01 使用 Claude 取得的关键成果 02 最新、最值得关注的 AI 新品资讯； 不定期赠送热门新品的邀请码、会员码； 最精准的AI产品曝光渠道 超级 Agents（Super Agent）推出 4 ...

AI 搜索 Agent 产品 Genspark 近期被 Anthropic 官方点名了。 邀请从业者、开发人员和创业者，飞书扫码加群： 进群后，你有机会得到： 01 使用 Claude 取得的关键成果 「 Less structure, more intelligence .」是 AI 搜索 Agent 产品 Genspark 一直以来坚持的基本原则。 Genspark 团队认为， 过度结构化的工作流程会限制创造力和深度，赋予专业 Agent 更多自主权，自由 选择并灵活运用多种工具来处理问题，反而能释放出更强的能力。 而 Genspark 灵活、能够动态协调的专业 Agent 的背后，是基于 Anthropic 的 Claude 模型的能力。 Anthropic 官网近期发布了一篇关于 Genspark 的案例研究文章，详细介绍了 Genspark 如何突破传统固定 搜索工作流程的局限、选择 Claude 实现自适应智能以及 Claude 如何驱动其动态协调的「Super Agent」 等内容。 以下为文章全文内容。 超 6000 人的「AI 产品市集」社群！不错过每一款有价值的 AI 应用。 02 最新、 ...

Prelude Therapeutics (PRLD) FY Conference June 11, 2025 09:20 AM ET Speaker0 Are necessary for a successful SMARK A2 directed agent? Obviously, sounds like the greater over inhibitor is one of the But what are some of Speaker1 the key properties you think are necessary for this kind of agent to be successful? Yes. So we know from our preclinical models that if you hit both four and two that you have quite a bit of toxicity. And so the degradation of II allows and selectivity and potency for II actually allo ...

Kymera Therapeutics (KYMR) FY Conference June 10, 2025 03:20 PM ET Speaker0 Hi, Speaker1 everyone. Good afternoon. Thanks so much for joining us. I'm Andrea Newkirk, one of the biotech analysts here at GS. And I'm really pleased to be joined by Nella Manolfe, founder, president, and CEO of Chimera. Thanks so much. Speaker0 Thanks for having us. Speaker1 Yeah, of course. So maybe before we dig into the data that you just presented last week for your STAT6 program, I thought maybe we could start with a overvi ...

Key Takeaways RTX unit Raytheon won a $646.5M contract for AN/SPY-6(V) radar hardware from the U.S. Navy. The radars offer longer range, higher sensitivity and multi-threat tracking across Navy ships. RTX benefits from rising defense spending and strong global demand for advanced military radars.RTX Corporation’s (RTX) business segment, Raytheon, recently secured a modification contract worth $646.5 million to exercise options for hardware production of the AN/SPY-6(V) family of radars. The award has been ...

Why do you think it's my responsibility to make you better as professionals. you. Seriously, if you're not going to take the time to make yourself valuable, to embrace reality, you're doomed. I'm not going to help you.If you don't want to do this, you're either going to be poor or a burden on society. And again, this is a part of this awakening. Wake the up. Grow up.There's not going to be demand for people that cannot upgrade themselves. people that are having a bad time coping with reality and understandi ...